FDA-Drug2017-10-11Class III
Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial. Intravenous, Intramuscular, Subcutaneous Use, Rx Only, Hospira, Inc., Lake Forest IL USA, NDC 0406-2336-10.
Pfizer Inc.
Hazard
CGMP Deviations: Firm failed to control impurity for color change at the API stage.
Sold states
Nationwide
Affected count
32,276 10 mL vials
Manufactured in
235 E 42nd St, N/A, New York, NY, United States
Products
Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial. Intravenous, Intramuscular, Subcutaneous Use, Rx Only, Hospira, Inc., Lake Forest IL USA, NDC 0406-2336-10.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0001-2018Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief